Avalo Therapeutics (AVTX)
NASDAQ:AVTX
Holding AVTX?
Track your performance easily

Avalo Therapeutics (AVTX) Balance Sheet

885 Followers

Avalo Therapeutics Balance Sheet

Avalo Therapeutics's total assets for Q2 2024 were $108.31M, a decrease of -12.46% from the previous quarter. AVTX total liabilities were $110.46M for the fiscal quarter, a -53.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 20.99M$ 28.55M$ 80.21M$ 43.76M$ 36.11M
Total Liabilities
$ 13.69M$ 44.28M$ 57.13M$ 19.19M$ 15.11M
Total Equity Gross Minority
$ 7.30M$ -10.91M$ 23.08M$ 24.56M$ 21.00M
Total Capitalization
$ 28.55M$ 16.06M$ 88.75M$ 24.56M$ 21.00M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Avalo Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis